PE-backed Zealand Pharma Plans $140 Million IPO

Private equity backed Danish biotech firm Zealand Pharma aims to raise up to $140 million in an initial public offering, Reuters reported. The company will offer nearly 9 million new shares priced between 86 and 120 crowns ($16.2-22.6) each. The company expects its shares to begin trading on the Copenhagen bourse by November 19. Danish private equity firm Sunstone Capital is Zealand Pharma’s largest shareholder.

DealsNorth AmericaUSBriefs